Top Abstract Purchase Related
Home
>
Node
>
Subnode

Plasma thrombomodulin and alpha 2-plasmin inhibitor-plasmin complex are elevated in active systemic lupus erythematosus

Kawakami, M.; Kitani, A.; Hara, M.; Harigai, M.; Suzuki, K.; Kawaguchi, Y.; Ishii, H.; Kazama, M.; Kawagoe, M.; Nakamura, H.

Journal of Rheumatology 19(11): 1704-1709

1992

ISSN/ISBN: 0315-162X
PMID: 1337109
Document Number: 392775
Plasma levels of thrombomodulin and alpha 2-plasmin inhibitor-plasmin complex were measured by ELISA in patients with rheumatic diseases. Thrombomodulin levels in patients with active systemic lupus erythematosus (SLE) were significantly higher than those in patients with inactive SLE or in healthy controls. This suggests that thrombomodulin, normally a component of vascular endothelial cell membrane, is easily released to plasma in patients with active SLE. High titers of the thrombomodulin level and the correlated alpha 2-plasmin inhibitor-plasmin complex elevations imply vascular injury, and consequently, excessive fibrinolytic processes in active SLE.

Document emailed within 1 workday
Secure & encrypted payments

Fukuda, C.; Iijima, K.; Inoue, N.; Takashima, Y.; Urabe, C.; Nakamura, K. 1988: Clinical evaluation of alpha 2 plasmin inhibitor and alpha 2 plasmin inhibitor-plasmin complex by enzyme immunoassay method--with special reference to accident surgery Rinsho Byori. Japanese Journal of Clinical Pathology 36(3): 346-350
Kawai, Y.; Watanabe, K. 1989: Molecular markers of hemostatic-mechanisms--plasmin-alpha 2 plasmin inhibitor complex Rinsho Byori. Japanese Journal of Clinical Pathology 37(3): 248-255
Takada, A.; Ito, T.; Takada, Y. 1980: Interaction of plasmin with tranexamic acid and alpha 2 plasmin inhibitor in the plasma and clot Thrombosis and Haemostasis 43(1): 20-23
Ichinose, A.; Sakata, Y.; Aoki, N. 1982: Reactions of alpha 2 plasmin inhibitor to plasmin and fibrin; its significance in fibrinolysis inhibition and hemostasis Rinsho Byori. Japanese Journal of Clinical Pathology Suppl 50: 178-188
Inman, R.D.; Harpel, P.C. 1986: Alpha 2-plasmin inhibitor-plasmin complexes in synovial fluid Journal of Rheumatology 13(3): 535-537
Yoshikawa, Y.; Sakata, Y. 1987: Alpha 2-Plasmin inhibitor Rinsho Byori. Japanese Journal of Clinical Pathology Spec no 70: 210-216
Wolf, P. 1979: The plasminogen content of commercial preparations and of normal donor plasma in relation to the plasmin content of the 1st international plasmin reference preparation Thrombosis and Haemostasis 42(2): 582-595
Kamiya, T.; Takamatsu, J.; Koie, K.; Kohakura, M. 1981: Metabolism of alpha 2-plasmin inhibitor ( alpha 2-PI) in a patient with congenital alpha 2-Pi deficiency Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 44(7): 1513-1519
Takase, T.; Yoshikawa, N.; Okamoto, H.; Yasui, M.; Fujimura, Y.; Fukui, H.; Kato, K. 1984: Enzyme immunoassay of alpha 2-plasmin inhibitor Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 47(1): 158-163
Tatematsu, M.; Higa, A.; Sunagawa, H.; Ikehara, O.; Shiohira, Y. 1998: Dialysis for a patient who had congenital deficiency of alpha 2-plasmin inhibitor Clinical Nephrology 49(5): 335-336
Du, X.H.; Glas-Greenwalt, P.; Kant, K.S.; Allen, C.M.; Hayes, S.; Pollak, V.E. 1985: Nephrotic syndrome with renal vein thrombosis: pathogenetic importance of a plasmin inhibitor (alpha 2-antiplasmin) Clinical Nephrology 24(4): 186-191
Miyauchi, Y.; Mii, Y.; Aoki, M.; Tamai, S.; Takahashi, Y.; Yoshioka, A. 1996: Operative treatment of intramedullary hematoma associated with congenital deficiency of alpha 2-plasmin inhibitor, A report of three cases Journal of Bone and Joint Surgery. American Volume 78(9): 1409-1414
Dubois, E.L.; Chandor, S.; Friou, G.J.; Bischel, M. 1971: Progressive systemic sclerosis and localized scleroderma morphea with positive lupus erythematosus cell test and unusual systemic manifestations compatible with systemic lupus erythematosus presentation of 14 cases including 1 set of identical twins 1 with scleroderma and the other with systemic lupus erythematosus review of the literature Medicine (Baltimore) 50(3): 199-222
Carsons, S. 1987: High levels of fibronectin fragments in the plasma of a patient with active systemic lupus erythematosus Journal of Rheumatology 14(5): 1052-1054
Kotyla, P.J.; Sliwinska-Kotyla, B.; Kucharz, E.J. 2006: Tumor necrosis factor-alpha as a potential target in the treatment of systemic lupus erythematosus: a role for the HMG-CoA reductase inhibitor simvastatin Journal of rheumatology 33(11): 2361-3; author reply 2363
Aoki, N. 1993: Clot retraction increases clot resistance to fibrinolysis by condensing alpha 2-plasmin inhibitor crosslinked to fibrin Thrombosis and Haemostasis 70(2): 376
Miyatani, K.; Fukui, I. 1971: Ultramicro determination of plasmin using fibrin plate. 1. Determination of plasmin activity Rinsho Byori. Japanese Journal of Clinical Pathology 19(9): 641-644
Carr, R.; Forsyth, S.; Sadi, D. 1987: Abnormal responses to ingested substances in murine systemic lupus erythematosus: apparent effect of a casein-free diet on the development of systemic lupus erythematosus in NZB/W mice Journal of Rheumatology. Suppl 14(Suppl 13): 158-165
Musatov, M.I.; Zhabin, S.G.; Konenkov, V.I.; Zorin, N.A. 1994: The effect of plasmin and its complexes with alpha 2-macroglobulin and alpha 2-antiplasmin on the proliferative activity of human lymphocytes Biulleten' Eksperimental'noi Biologii i Meditsiny 118(9): 304-305
Pacilio, M.; Migliaresi, S.; Meli, R.; Ambrosone, L.; Bigliardo, B.; Di Carlo, R. 2001: Elevated bioactive prolactin levels in systemic lupus erythematosus--association with disease activity Journal of Rheumatology 28(10): 2216-2221